CA2434337A1 - Combination of probiotics - Google Patents

Combination of probiotics Download PDF

Info

Publication number
CA2434337A1
CA2434337A1 CA002434337A CA2434337A CA2434337A1 CA 2434337 A1 CA2434337 A1 CA 2434337A1 CA 002434337 A CA002434337 A CA 002434337A CA 2434337 A CA2434337 A CA 2434337A CA 2434337 A1 CA2434337 A1 CA 2434337A1
Authority
CA
Canada
Prior art keywords
combination
bifidobacterium
combination according
lactobacillus rhamnosus
dsm7067
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002434337A
Other languages
French (fr)
Other versions
CA2434337C (en
Inventor
Annika Mayra-Makinen
Tarja Suomalainen
Outi Vaarala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chr Hansen AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2434337A1 publication Critical patent/CA2434337A1/en
Application granted granted Critical
Publication of CA2434337C publication Critical patent/CA2434337C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/61—Propionibacterium
    • A23V2400/617—Freudenreichii

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Revetment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

The invention relates to a probiotic combination comprising different combinations of lactobacilli, propionic acid bacteria and/or bifidobacteria.
The probiotics are preferably combined with a suitable prebiotic to form a synbiotic. The combination of the invention can be consumed as such or combined with a suitable foodstuff or pharmaceutical product, and it is therapeutically useful for example for stimulating the immune system and for general health improvement.

Claims (14)

1. A combination characterized in that it comprises at least three of the microorganisms Lactobacillus rhamnosus LGG (ATCC 53103), Lactobacillus rhamnosus LC705 (DSM 7061), Propionibacterium freudenreichii ssp. shermanii PJS (DSM7067) and a bifidobacterium, or Propionibacterium freudenreichii ssp. shermanii PJS (DSM7067) and a bifidobacterium.
2. A combination according to claim 1, characterized in that it comprises Lactobacillus rhamnosus LGG (ATCC 53103), Lactobacillus rhamnosus LC705 (DSM 7061), Propionibacterium freudenreichii ssp.
shermanii PJS (DSM7067) and a bifidobacterium.
3. A combination according to claim 1, characterized in that it comprises Propionibacterium freudenreichii ssp. shermanii PJS (DSM7067) and a bifidobacterium.
4. A combination according to any one of claims 1 to 3, characterized in that the bifidobacterium is Bifidobacterium infantis Bbi99 (DSM 13692).
5. A combination according to any one of claims 1 to 4, characterized in that it further comprises conventional starter microbes.
6. A combination according to any one of claims 1 to 5, characterized in that it also comprises a prebiotic or that it is used together with a prebiotic.
7. A combination according to claim 6, characterized in that the prebiotic is an oligosaccharide, xylo-oligomer or polydextrose.
8. A combination according to claim 7, characterized in that the prebiotic is a galacto-oligosaccharide (GOS).
9. A combination according to any one of claims 1 to 8 to be used as a therapeutic substance.
10. A combination comprising at least two of the following microorganisms: Lactobacillus rhamnosus LGG (ATCC 53103), Lactobacillus rhamnosus LC705 (DSM 7061), Propionibacterium freudenreichii ssp.
shermanii PJS (DSM7067) and a bifidobacterium, although not the combination Lactobacillus rhamnosus LGG (ATCC 53103) and a bifidobacterium, to be used as a therapeutic substance.
11. Use of a combination according to any one of claims 1 to 8 in food industry, pharmaceutical industry, or in the manufacture of health-promoting products or natural products.
12. Use according to claim 11, characterized in that the combination is added to a dairy product, drink, juice, soup or children's food.
13. Use according to claim 11, characterized in that the combination is prepared in a single dose form.
14. Use according to claim 13, characterized in that the dose form is a capsule.
CA2434337A 2001-01-25 2002-01-17 Combination of probiotics Expired - Fee Related CA2434337C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20010157A FI109602B (en) 2001-01-25 2001-01-25 Probiotkombination
FI20010157 2001-01-25
PCT/FI2002/000035 WO2002060276A1 (en) 2001-01-25 2002-01-17 Combination of probiotics

Publications (2)

Publication Number Publication Date
CA2434337A1 true CA2434337A1 (en) 2002-08-08
CA2434337C CA2434337C (en) 2010-12-21

Family

ID=8560139

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2434337A Expired - Fee Related CA2434337C (en) 2001-01-25 2002-01-17 Combination of probiotics

Country Status (25)

Country Link
US (1) US8309073B2 (en)
EP (1) EP1359816B1 (en)
JP (1) JP3984546B2 (en)
KR (1) KR20040012717A (en)
CN (1) CN100400645C (en)
AT (1) ATE297664T1 (en)
AU (1) AU2002229787B2 (en)
BR (1) BRPI0206689B1 (en)
CA (1) CA2434337C (en)
CZ (1) CZ301673B6 (en)
DE (1) DE60204662T2 (en)
DK (1) DK1359816T3 (en)
EE (1) EE05299B1 (en)
ES (1) ES2243697T3 (en)
FI (1) FI109602B (en)
HK (1) HK1061501A1 (en)
HR (1) HRP20030586B8 (en)
HU (1) HU225790B1 (en)
NO (1) NO325463B1 (en)
NZ (1) NZ527172A (en)
PL (1) PL204245B1 (en)
PT (1) PT1359816E (en)
RU (1) RU2291899C2 (en)
WO (1) WO2002060276A1 (en)
ZA (1) ZA200305458B (en)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109602B (en) * 2001-01-25 2002-09-13 Valio Oy Probiotkombination
US20030175305A1 (en) * 2002-01-08 2003-09-18 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
DE10206995B4 (en) * 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Micronutrient combination product with pro- and prebiotics
ITMI20020399A1 (en) 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P DIETARY AND / OR PHARMACEUTICAL COMPOSITIONS FOR HUMAN AND / OR ANIMAL USE BASED ON MICROBIAL PROBIOTIC PREPARATIONS
EP1374878A1 (en) * 2002-06-20 2004-01-02 N.V. Nutricia Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
FI113057B (en) * 2002-11-04 2004-02-27 Valio Oy Use of Lactobacillus rhamnosus LGG deposited under ATCC 53103, Lactobacillus rhamnosus LC705, DSM 7061, and Propionibacterium freudenreichii PJS, DSM 7067 for preparing a product for inhibiting yeast
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
SE526711C2 (en) 2003-01-31 2005-10-25 Probi Ab Novel strains of Bifidobacterium having ability to survive in intestinal tract and produce glutamine and arginine in vivo, useful for preparing medicament for treatment of intensive care patients with intestinal failure
EP1638414B1 (en) * 2003-06-23 2009-06-17 Nestec S.A. Infant or follow-on formula
EP1638415B1 (en) * 2003-06-23 2010-12-15 Nestec S.A. Infant or follow-on formula
NZ546664A (en) * 2003-10-24 2009-04-30 Nutricia Nv Synbiotic composition for infants
US20050208034A1 (en) * 2004-03-17 2005-09-22 Jordan Lazonia V Natural vaginal yeast infection control
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
PT1629850E (en) * 2004-08-24 2007-08-14 Nutricia Nv Nutritional composition comprising indigestible oligosaccharides
ITMI20042189A1 (en) * 2004-11-16 2005-02-16 Anidral Srl COMPOSITION BASED ON PROBIOTIC BACTERIA AND ITS USE IN THE PREVENTION OF E-OR IN THE TREATMENT OF PATHOLOGIES AND-OR RESPIRATORY INFECTIONS AND IN THE IMPROVEMENT OF INTESTINAL FUNCTIONALITY
BRPI0607743B1 (en) * 2005-02-28 2020-09-15 N. V. Nutricia PREBIOTIC NUTRITIONAL COMPOSITION FOR BABIES AND USE OF A PREBIOTIC NUTRITIONAL COMPOSITION FOR BABIES
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
KR101411144B1 (en) * 2005-07-26 2014-06-26 네스텍 에스.아. Anti-obesity agent and anti-obesity food
RU2417092C2 (en) * 2005-10-06 2011-04-27 Проби Аб Lactobacillus application for treating autoimmune diseases
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US9005682B2 (en) * 2006-03-07 2015-04-14 Nestec S.A. Synbiotic mixture
EP1993577B1 (en) * 2006-03-10 2014-02-12 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth
US20100166721A1 (en) * 2006-06-09 2010-07-01 Fabiola Masri Probotic compositions and uses thereof
WO2007140622A1 (en) * 2006-06-09 2007-12-13 Nutravital Inc. Dairy-derived probiotic compositions and uses thereof
US7387427B2 (en) 2006-10-20 2008-06-17 Bristol-Myers Squibb Company Method for blending heat-sensitive material using a conical screw blender with gas injection
WO2008054193A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Nutritional products that comprise saccharide oligomers
RU2454239C2 (en) * 2007-02-22 2012-06-27 Юрген ШРЕЗЕНМЕИР Probiotic gram-positive bacteria for human allergy prevention, inhibition or elimination
CN105796607A (en) * 2007-02-28 2016-07-27 Mjn 美国控股有限责任公司 Product containing inactivated probiotic for children or infants
ES2322116B1 (en) 2007-03-12 2010-03-29 Consejo Superior Investig. Cientificas ANTIBODY PRODUCING MICROORGANISM, ELEMENTS REQUIRED FOR OBTAINING, ANTIBODIES AS WELL PRODUCED, THERAPEUTIC COMPOSITIONS AND THEIR APPLICATIONS.
CN101273736B (en) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 Method for preparing fermented milk having higher viable counts at normal temperature
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
FI121912B (en) * 2008-02-05 2011-06-15 Valio Oy New use of probiotics
CN102488716B (en) * 2008-02-29 2013-09-11 株式会社明治 Anti-allergic agent
FI20080321A0 (en) * 2008-04-25 2008-04-25 Eino Elias Hakalehto Procedure for maintaining bacterial balance in the intestinal tract
US20120021418A1 (en) * 2008-06-13 2012-01-26 Kabushiki Kaisha Yakult Honsha Gene that imparts oxygen resistance and application thereof
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
FR2933848B1 (en) 2008-07-18 2019-08-09 Roquette Freres COMPOSITION OF SOLUBLE INDIGESTIBLE FIBERS AND EUKARYOTIC ORGANISMS HAVING POLYSACCHARIDE WAVES USED IN THE WELL-BEING FIELD
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
MX354119B (en) * 2008-11-21 2018-02-14 Antonio Cruz Serrano Jose Method for obtaining a mixture of probiotics, nutrient prebiotics having synergistic symbiotic action.
US8445426B2 (en) 2009-02-02 2013-05-21 Valio Ltd. Peptides and methods for producing them
EP2216035A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus CNCM I-4096 and weight control
EP2216036A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
SG10201901259RA (en) 2009-02-24 2019-03-28 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
WO2010103132A1 (en) * 2009-03-10 2010-09-16 Hero España, S.A. Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk
JP2012520325A (en) * 2009-03-13 2012-09-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Prebiotic oligosaccharide
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
CA2763074C (en) 2009-05-26 2021-02-23 Moti Harel Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
GB0915315D0 (en) * 2009-09-03 2009-10-07 Univ Manchester Use of non-digestible oligosaccharides
FI20096058A0 (en) * 2009-10-13 2009-10-13 Valio Oy Compositions and related methods and uses
CN102665738B (en) * 2009-12-10 2015-07-01 株式会社明治 Prophylactic composition for influenza infection
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
FR2955774A1 (en) 2010-02-02 2011-08-05 Aragan PREPARATION FOR TREATING PONDERAL EXCES AND ASSOCIATED DISORDERS AND APPLICATIONS THEREOF
DE102010009582A1 (en) * 2010-02-05 2011-08-11 Vitacare GmbH & Co. KG, 60318 Agent for use in lactase deficiency and lactose intolerance
CN101810222A (en) * 2010-04-23 2010-08-25 陕西农产品加工技术研究院 Synbiotic goat milk powder
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8911348B2 (en) 2010-09-02 2014-12-16 Boston Scientific Scimed, Inc. Pelvic implants and methods of implanting the same
CN102524391B (en) * 2010-12-21 2013-11-13 内蒙古蒙牛乳业（集团）股份有限公司 Fermented dairy product containing compound prebiotic and probiotic group
WO2012108830A1 (en) 2011-02-09 2012-08-16 Lavivo Ab Synbiotic compositions for restoration and reconstitution of gut microbiota
US20120269929A1 (en) * 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
FR2974512B1 (en) * 2011-04-28 2013-11-08 Roquette Freres ANTI-INFLAMMATORY COMPOSITION OF INTESTINE COMPRISING MALTITOL
US9125935B1 (en) * 2011-05-31 2015-09-08 Nutech Ventures Probiotics and methods of obtaining same
RU2482176C1 (en) * 2012-02-16 2013-05-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия" Министерства здравоохранения Российской Федерации"(ГБОУ ВПО Тверская ГМА Минздрава России) Lactobacillus rhamnosus BACTERIA STRAIN HAVING WIDE RANGE OF ANTAGONISTIC ACTIVITY WITH RESPECT TO PATHOGENS AND OPPORTUNISTIC PATHOGENS
AU2013265388B2 (en) * 2012-05-21 2015-10-29 Dupont Nutrition Biosciences Aps Strains of propionibacterium
JP6286434B2 (en) * 2012-09-20 2018-02-28 プロセラ インコーポレイテッド Probiotic compositions and methods for the treatment of obesity and obesity-related diseases
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
US20150352162A1 (en) * 2013-01-21 2015-12-10 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
PL3328215T3 (en) 2015-07-29 2021-12-13 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
RS57471B1 (en) 2015-12-17 2018-09-28 Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu New probiotic starter culture for human and animal use
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
ITUA20163807A1 (en) * 2016-05-25 2017-11-25 Univ Degli Studi Di Foggia METHOD FOR THE PRODUCTION OF PROBIOTIC MICROBIAL BIOFILMS AND RELATED USES
JP2020508700A (en) 2017-03-03 2020-03-26 ビオミレニア ソシエテ パ アクシオンス シンプリフィエ Microparticles for culturing and testing cells
US10695386B2 (en) 2017-05-11 2020-06-30 Shayne K. Morris Skin microbiome colonizer formulations and methods for use
IT201800003128A1 (en) * 2018-02-28 2019-08-28 Propharma Soc A Responsabilita Limitata Semplificata PROBIOTIC COMPOSITION
US11291696B2 (en) 2018-04-11 2022-04-05 Shayne Morris Pairing probiotics and prebiotics, methods for growth and use, separately and in combination
US11168299B2 (en) 2018-04-11 2021-11-09 Shayne Morris Pairing probiotics and prebiotics, methods for growth and use, separately and in combination
CN109757731A (en) * 2019-03-14 2019-05-17 广州普维君健药业有限公司 Alleviate the probiotic composition and its preparation method and application of lactose intolerance
EP3760054A1 (en) * 2019-07-02 2021-01-06 Pepticus s.r.o. A method of preparing an individual probiotic composition according to analysis of the microbiome and medical history for human or veterinary use
CN111450122B (en) * 2019-11-02 2023-04-25 吉安诺惠诚莘科技有限公司 Composite microbial inoculum and application thereof in skin repair
KR102215596B1 (en) * 2019-12-11 2021-02-15 주식회사 에이치이엠 A novel strain of Streptococcus thermophilus HEM 14, and composition for improving gut environment comprising the strain or its culture fluid
KR102254752B1 (en) 2020-01-09 2021-05-24 한국식품연구원 New Lactobacillus plantarum WiKim87 and use thereof
KR102254751B1 (en) 2020-01-09 2021-05-24 한국식품연구원 New Lactobacillus plantarum WiKim83 and use thereof
CN114317320B (en) * 2020-08-24 2022-12-27 汤臣倍健股份有限公司 Bifidobacterium breve 207-1 and application thereof
CN113005049B (en) * 2020-12-30 2022-11-01 江南大学 Bifidobacterium breve capable of relieving diarrhea and application thereof
KR20220099914A (en) * 2021-01-07 2022-07-14 (주)에스앤에이치바이오텍 Composition for Activating Probiotics through Inhibition of Harmful Bacteria
EP4373503A1 (en) * 2021-07-20 2024-05-29 ETH Zurich Treatment and/or prevention of digestive disorder by a bacterial composition of propionibacterium freudenreichii and bifidobacterium longum

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
CZ281386B6 (en) * 1991-01-29 1996-09-11 MILCOM a.s. Výzkumný ústav mlékárenský Probiotic preparations for people and animal nutrition ns process for preparing thereof
FI92498C (en) 1992-06-10 1994-11-25 Valio Meijerien New microorganism strain, bacterial preparations containing it and their use for controlling yeast and mold
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
US5529753A (en) * 1993-07-09 1996-06-25 Dade International Inc. System for ultrasonic energy coupling by irrigation
US5529793A (en) * 1994-11-16 1996-06-25 Nutrition Physiology Corporation Compositions for improving the utilization of feedstuffs by ruminants
FI104465B (en) * 1995-06-14 2000-02-15 Valio Oy Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use
CN1211189A (en) 1996-02-14 1999-03-17 普罗克特和甘保尔公司 Urogenital and intestinal disorder compositions comprising a substrance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
AU1758197A (en) 1996-02-14 1997-09-02 Procter & Gamble Company, The Urogenital and intestinal compositions
AUPN881396A0 (en) 1996-03-20 1996-04-18 Arnott's Biscuits Limited Enhancement of microbial colonization of the gastrointestinal tract
US5902578A (en) 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
CZ291297B6 (en) * 1996-12-02 2003-01-15 Jevgenij Anatolievič Gutkevič Mixture for the preparation of ice cream
EP0856259B1 (en) 1996-12-23 1998-08-12 SITIA-YOMO S.p.A. Composition for feed use comprising lyophilized live lactic bacteria
EP2241616B1 (en) 1997-08-21 2012-11-28 New Zealand Dairy Board Immunity enhancing lactic acid bacteria
EP0904784A1 (en) 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
CN1119154C (en) * 1998-01-20 2003-08-27 上海信谊药业有限公司 Live triple bifidobacteria preparation and preparing method thereof
US6080401A (en) 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
NL1010770C2 (en) 1998-12-09 2000-06-13 Nutricia Nv Preparation containing oligosaccharides and probiotics.
EP1020123A1 (en) 1999-01-18 2000-07-19 Sitia-Yomo S.p.A. Beverages containing live lactic bacteria
CA2374937A1 (en) * 1999-05-25 2000-11-30 Gregor Reid Oral administration of lactobacillus for the maintenance of health in women
FI109602B (en) * 2001-01-25 2002-09-13 Valio Oy Probiotkombination
CN1164186C (en) * 2001-04-29 2004-09-01 上海光明乳业股份有限公司 Milk with probiotics and its production process
CN1132927C (en) * 2001-07-19 2003-12-31 上海交通大学 Method for preparing probiotics by co-fermentation of probiotics and fungus

Also Published As

Publication number Publication date
DE60204662T2 (en) 2006-05-18
CA2434337C (en) 2010-12-21
FI109602B (en) 2002-09-13
HK1061501A1 (en) 2004-09-24
NO20033283D0 (en) 2003-07-21
CZ301673B6 (en) 2010-05-19
PT1359816E (en) 2005-10-31
NZ527172A (en) 2004-11-26
WO2002060276A1 (en) 2002-08-08
AU2002229787B2 (en) 2007-09-06
EP1359816A1 (en) 2003-11-12
EE05299B1 (en) 2010-06-15
RU2291899C2 (en) 2007-01-20
US8309073B2 (en) 2012-11-13
PL363366A1 (en) 2004-11-15
ATE297664T1 (en) 2005-07-15
JP2004524836A (en) 2004-08-19
FI20010157A0 (en) 2001-01-25
WO2002060276A8 (en) 2003-10-30
CN1487798A (en) 2004-04-07
CZ20031915A3 (en) 2004-01-14
CN100400645C (en) 2008-07-09
HRP20030586A2 (en) 2005-06-30
FI20010157A (en) 2002-07-26
ES2243697T3 (en) 2005-12-01
EP1359816B1 (en) 2005-06-15
WO2002060276A9 (en) 2002-10-03
BR0206689A (en) 2004-02-03
HU225790B1 (en) 2007-09-28
RU2003125858A (en) 2005-02-20
PL204245B1 (en) 2009-12-31
DK1359816T3 (en) 2005-08-15
HUP0401017A3 (en) 2005-06-28
NO325463B1 (en) 2008-05-05
HRP20030586B8 (en) 2007-09-30
HUP0401017A2 (en) 2004-08-30
JP3984546B2 (en) 2007-10-03
HRP20030586B1 (en) 2007-06-30
ZA200305458B (en) 2004-10-15
US20040062758A1 (en) 2004-04-01
NO20033283L (en) 2003-09-24
BRPI0206689B1 (en) 2016-02-10
EE200300351A (en) 2003-12-15
KR20040012717A (en) 2004-02-11
DE60204662D1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
CA2434337A1 (en) Combination of probiotics
Ouwehand et al. Probiotics: mechanisms and established effects
Chandan Enhancing market value of milk by adding cultures
Sharma et al. Probiotics: a comprehensive approach toward health foods
RU2593716C2 (en) Frozen confections containing probiotic micro-organisms
US7981412B2 (en) Food containing a probiotic and an isolated β-glucan and methods of use thereof
EP1947962B1 (en) Edible product containing ginseng polysaccharides and beneficial bacteria
RU2011150197A (en) PROBIOTIC DIET ADDITIVE FOR ORAL ADMINISTRATION
JP2004524836A5 (en)
HUP0100428A2 (en) Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain
Umer Khan Probiotics in dairy foods: a review
Sarkar Effect of probiotics on biotechnological characteristics of yoghurt: A review
EP3593639A1 (en) Probiotic fortified food products and methods of manufacture
JP5238166B2 (en) Interleukin 12 production inhibitor
Yoon et al. Studies on the biological activity of synbiotics: A review
JPWO2020116511A1 (en) Composition for suppressing norovirus infection
EP1405641A2 (en) Pharmaceutical and/or nutraceutical composition comprising a combination of probiotic non sporogenic microorganisms and spores of Bacillus subtilis and/or Bacillus clausii
Schellack et al. Overview of prebiotics, probiotics and synbiotics
EP3019037B1 (en) An oral composition comprising l. rhamnosus gg for use in the prevention and/or treatment of herpes labialis
Rutherfurd-Markwick et al. Probiotics and immunomodulation
Combrinck et al. Prebiotics, probiotics and synbiotics: An update
Combrinck et al. Probiotics and Prebiotics
Flores-Maltos et al. Synergism in Food Trends: The Key to a Healthy Life
Minj et al. 10 Beneficial Effects of Dairy
Combrinck et al. Probiotics and prebiotics

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20210831

MKLA Lapsed

Effective date: 20200117